Kalvista Pharmaceuticals Inc (KALV.OQ)
KALV.OQ on NASDAQ Stock Exchange Global Market
19.66USD
2:29am IST
19.66USD
2:29am IST
Change (% chg)
$0.81 (+4.30%)
$0.81 (+4.30%)
Prev Close
$18.85
$18.85
Open
$18.54
$18.54
Day's High
$19.77
$19.77
Day's Low
$18.30
$18.30
Volume
13,361
13,361
Avg. Vol
26,848
26,848
52-wk High
$23.81
$23.81
52-wk Low
$7.74
$7.74
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Jul | 3.72 | -0.466 |
| FY 2018 | Apr '18 | 4.84 | -0.061 |
| Jan '18 | 2.33 | -0.485 | |
| Oct | 1.13 | -0.498 | |
| Jul | 0.10 | -0.507 | |
| FY 2017 | Apr '17 | 0.11 | -0.440 |
| Jan '17 | 0.25 | -0.998 | |
| FY 2016 | Sep '16 | 0.01 | -1.268 |
| Jun '16 | 0.01 | -3.907 | |
| Mar '16 | 0.01 | -3.513 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Apr-18 | 2 | 3.65 | 5.00 | 2.30 | -- |
| Quarter Ending Jan-19 | 5 | 3.80 | 4.30 | 3.00 | -- |
| Year Ending Apr-18 | 2 | 7.25 | 8.60 | 5.90 | -- |
| Year Ending Apr-19 | 5 | 15.16 | 16.62 | 12.70 | 14.40 |
| Year Ending Apr-20 | 5 | 23.94 | 43.80 | 10.00 | 28.80 |
| Earnings (per share) | |||||
| Quarter Ending Apr-18 | 2 | -0.35 | -0.26 | -0.44 | -- |
| Quarter Ending Jan-19 | 5 | -0.53 | -0.40 | -0.75 | -- |
| Year Ending Apr-18 | 2 | -1.84 | -1.74 | -1.93 | -- |
| Year Ending Apr-19 | 5 | -1.91 | -1.28 | -2.79 | -1.40 |
| Year Ending Apr-20 | 4 | -1.97 | -0.27 | -3.59 | -0.27 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 31.23 | 33.59 | |
| P/E High - Last 5 Yrs. | -- | 40.67 | 45.05 | |
| P/E Low - Last 5 Yrs. | -- | 24.06 | 24.37 | |
| Beta | -- | 0.92 | 0.91 | |
| Price to Sales (TTM) | 151.44 | 4.01 | 5.69 | |
| Price to Book (MRQ) | 2.63 | 5.04 | 5.11 | |
| Price to Tangible Book (MRQ) | 2.63 | 5.77 | 6.54 | |
| Price to Cash Flow (TTM) | -- | 23.28 | 23.52 | |
| % Owned Institutions | 80.82 | 0.96 | 1.86 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.54 | 1.48 | |
| Dividend Yield - 5 Year Avg | -- | 1.55 | 1.50 | |
| Dividend 5 Year Growth Rate | -- | 4.20 | 5.09 | |
| Payout Ratio(TTM) | -- | 45.75 | 43.86 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 1,271.43 | 2.38 | 7.42 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 1,503.45 | 4.87 | 5.86 | |
| Sales - 5 Yr. Growth Rate | -- | 10.03 | 10.16 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 87.02 | 17.59 | 21.17 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 75.80 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 9.81 | 10.63 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 15.39 | 15.17 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.20 | 2.26 |
| Current Ratio (MRQ) | 7.87 | 3.02 | 3.09 |
| LT Debt to Equity (MRQ) | 0.80 | 8.92 | 11.53 |
| Total Debt to Equity (MRQ) | 1.55 | 12.75 | 15.71 |
| Interest Coverage (TTM) | -29.72 | 35.11 | 32.22 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 54.28 | 54.07 | |
| Gross Margin - 5 Yr. Avg. | -- | 51.72 | 51.83 | |
| EBITD Margin (TTM) | -4,520.00 | -- | -- | |
| EBITD - 5 Yr. Avg | -- | 18.38 | 11.80 | |
| Operating Margin (TTM) | -4,529.25 | 14.42 | 4.85 | |
| Operating Margin - 5 Yr. Avg. | -- | 14.54 | 7.45 | |
| Pre-Tax Margin (TTM) | -4,120.21 | 14.94 | 5.82 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | 14.96 | 7.86 | |
| Net Profit Margin (TTM) | -4,120.21 | 11.15 | 2.08 | |
| Net Profit Margin - 5 Yr. Avg. | -- | 11.22 | 4.10 | |
| Effective Tax Rate (TTM) | -- | 23.47 | 23.39 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 23.63 | 24.13 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 1,003,835,245 | 905,634,050 | |
| Net Income/Employee (TTM) | -- | 119,027,143 | 107,327,020 | |
| Receivable Turnover (TTM) | -- | 5.83 | 5.95 | |
| Inventory Turnover (TTM) | -- | 2.68 | 3.63 | |
| Asset Turnover (TTM) | 0.01 | 1.00 | 0.97 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -55.70 | 12.00 | 11.52 | |
| Return on Assets - 5 Yr. Avg. | -- | 13.31 | 12.71 | |
| Return on Investment (TTM) | -60.80 | 15.57 | 15.05 | |
| Return on Investment - 5 Yr. Avg. | -- | 17.33 | 16.50 | |
| Return on Equity (TTM) | -61.05 | 16.94 | 16.62 | |
| Return on Equity - 5 Yr. Avg. | -- | 18.26 | 17.61 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -- | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Kalvista Pharmaceuticals Inc
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 71.02% |
| # of Holders: | 59 |
| Total Shares Held: | 12,201,766 |
| 3 Mo. Net Change: | 5,087,545 |
| # New Positions: | 28 |
| # Closed Positions: | 4 |
| # Increased Positions: | 40 |
| # Reduced Positions: | 13 |
| # Net Buyers: | 27 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.